Panagene Inc
KOSDAQ:046210
Panagene Inc
Operating Expenses
Panagene Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Panagene Inc
KOSDAQ:046210
|
Operating Expenses
-₩10.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
Celltrion Inc
KRX:068270
|
Operating Expenses
-₩400.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-21%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Expenses
-₩154.2B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Expenses
-₩128.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Expenses
-₩98B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Operating Expenses
-₩40.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
See Also
What is Panagene Inc's Operating Expenses?
Operating Expenses
-10.1B
KRW
Based on the financial report for Dec 31, 2023, Panagene Inc's Operating Expenses amounts to -10.1B KRW.
What is Panagene Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
Over the last year, the Operating Expenses growth was -25%. The average annual Operating Expenses growth rates for Panagene Inc have been -21% over the past three years , -12% over the past five years , and -5% over the past ten years .